Acute ischemic stroke is characterized by the sudden loss of blood circulation to an area of the brain, resulting in a corresponding loss of neurologic function. Acute ischemic stroke is caused by thrombotic or embolic occlusion of a cerebral artery and is more common than hemorrhagic stroke. Different imaging studies, including computed tomography, magnetic resonance imaging, computed tomographic angiography, magnetic resonance angiography, and perfusion studies, are useful for evaluation of acute stroke. Ischemic stroke is one of the leading causes of long-term disability and a third leading cause of death worldwide.
The global acute ischemic stroke diagnosis and treatment market report provides market size (Revenue US$ Million 2014 to 2021), market share, market trends and forecasts growth trends (CAGR%, 2017 to 2021).
The global acute ischemic stroke diagnosis and treatment market segmentation is based on diagnostics type (computed tomography, magnetic resonance imaging, ultrasound, cerebral angiography, nuclear imaging), and surgery types (carotid endarterectomy, angioplasty, endovascular mechanical thrombectomy).
The global acute ischemic stroke diagnosis and treatment market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and profiles of major competitors in the global market including company overview, financial snapshot, key products, technologies and services offered, and recent developments. The global acute ischemic stroke diagnosis and treatment market research report is divided by geography (regional and country based) into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World.
Major market players included in this report are Covidien plc, Johnson and Johnson, Stryker Corporation, Abbott Laboratories, Hitachi Medical Corporation, GE healthcare, Penumbra, Inc. and Philips Healthcare.